INDV Indivior Pharmaceuticals, Inc.
$34.72▲ +0.46%
Healthcare
Other
After hours
$35.50▲ +2.25%
Oct 27, 5:39 PM ET
Volume 2.08M
Avg Volume (10D) 2.16M
Key Metrics & Fundamentals
Market Cap
$4.10B
P/E Ratio
12.3
Div Yield
0.00%
52W Range
24.28 - 42.81
% vs 50 MA
-1.96%
% vs 200 MA
-2.61%
RSI-14
47.4
MACD Histogram
+0.0300
Beta (1Y vs SPY)
0.54
Free Cash Flow
$222.00M
Gross Rev
$343.00M
Gross Profit
$293.00M
EBITDA
$165.00M
COGS
$50.00M
Operating Exp
$134.00M
Operating Income
$159.00M
EBIT
$159.00M
Pretax Income
$160.00M
Net Income
$122.00M
EPS (Diluted)
0.98
Price & Volume History
Loading chart…
Recent News
MSG Rangers and Huron Consulting Group Set to Join S&P SmallCap 600
PR Newswire · Oct 22, 2026 6:08 PM ET
Indivior to Report Third Quarter 2026 Financial Results
GlobeNewswire · Oct 19, 2026 8:30 AM ET
Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend
GlobeNewswire · Sep 17, 2026 7:00 AM ET
5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
Zacks · Sep 14, 2026 9:30 AM ET
Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound?
Zacks · Sep 2, 2026 11:30 AM ET
Indivior Pharmaceuticals Inc. (INDV) Loses 12.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks · Aug 31, 2026 9:35 AM ET
3 Reasons Why Growth Investors Shouldn't Overlook Indivior Pharmaceuticals Inc. (INDV)
Zacks · Aug 27, 2026 12:45 PM ET
Indivior Pharmaceuticals (INDV) Could Be 30% Undervalued On Its Cost Reset Plan
Simply Wall St. · Aug 21, 2026 10:11 PM ET
Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
Zacks · Aug 21, 2026 12:40 PM ET
Should Investors Buy INDV as Sublocade Growth Meets Rising Risks?
Zacks · Aug 21, 2026 10:48 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See INDV's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.